Salako L A, Walker O, Sowunmi A
Department of Pharmacology and Therapeutics, College of Medicine, University of Ibadan, Nigeria.
Trans R Soc Trop Med Hyg. 1994 Jan-Feb;88(1):89-91. doi: 10.1016/0035-9203(94)90515-0.
We have compared the efficacy of intramuscular artemether against intramuscular sulfadoxine-pyrimethamine in an open randomized study in children with severe but uncomplicated malaria. Parasite clearance time and fever clearance time were faster with artemether. The parasitological clearance on day 14 was 100% for artemether and 98% for sulfadoxine-pyrimethamine, but 8 patients in the artemether group and 1 in the other group had a recrudescence of parasitaemia. There was no toxic reaction of note in either group. We therefore suggest that artemether is a good alternative to the currently used drugs in the parenteral treatment of severe but uncomplicated malaria and may be useful in preventing the possible development of cerebral malaria.
在一项针对患有严重但无并发症疟疾儿童的开放性随机研究中,我们比较了肌肉注射蒿甲醚与肌肉注射磺胺多辛-乙胺嘧啶的疗效。蒿甲醚治疗组的寄生虫清除时间和发热清除时间更快。第14天的寄生虫学清除率,蒿甲醚治疗组为100%,磺胺多辛-乙胺嘧啶治疗组为98%,但蒿甲醚治疗组有8例患者、另一组有1例患者出现了寄生虫血症复发。两组均未观察到明显的毒性反应。因此,我们建议蒿甲醚是目前用于严重但无并发症疟疾肠外治疗的药物的良好替代品,可能有助于预防脑型疟疾的可能发展。